Article

The biosimilar decade: Regulatory milestones and a look ahead

Since the first FDA approval of a biosimilar drug in March of 2015, the market for this category has steadily expanded to include more than 60 different products from dozens of manufacturers. In the following timeline, Cencora presents the key regulatory events that have helped this critical industry gain its footing over the last decade. With continued growth in the biosimilars market, we also look ahead to the factors we believe will be most important to its future success.

See our timeline to discover how a decade of approvals is shaping the future of this market.
biosimilar_vials

Biosimilars pipeline report

This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market. 

Related resources

Article

Tips for partnering with health systems: A critical step for CGT commercialization
Learn more
World Courier team member presents at a large LED digital display

Webinar

Navigating the healthcare policy landscape: Key insights for managed care and the life sciences industry
Learn more
people working around a table

Article

Building revenue with mature products in a time of market flux
Learn more

Connect with our team

We are here to support you with innovative solutions to help increase access to these emerging therapies.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.